Premium
Case Report. Sporotrichosis successfully treated with itraconazole in Japan
Author(s) -
Noguchi H.,
Hiruma M.,
Kawada A.
Publication year - 1999
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1046/j.1439-0507.1999.00484.x
Subject(s) - sporotrichosis , itraconazole , medicine , erythema , lesion , adverse effect , surgery , dermatology , antifungal
A case of lymphocutaneous sporotrichosis that had developed from the dorsum nasi to the left buccal region of a 65‐year‐old woman was treated with itraconazole 100 mg day −1 . The lesion healed in 10 weeks after starting treatment leaving crusts, mild erythema and pigmentation, and the treatment was completed 16 weeks after the start of treatment. Neither adverse reactions nor abnormal clinical laboratory values were noted. Until the present time, 1 year and 2 months after the completion of treatment, no recurrence has been observed. In Japan, 43 cases of sporotrichosis have been treated with itraconazole, and 38 cases (88%) have been assessed as effective or better. The mean dose of itraconazole and the mean duration of administration are 100 mg day −1 and 11 weeks, respectively, in these reported Japanese cases. The use of itraconazole is expected to be one of the effective therapies for sporotrichosis.